PreDxion Bio logo — Pioneering accessible at-home diagnostics with a breakthroug...

PreDxion Bio

Pioneering accessible at-home diagnostics with a breakthrough saliva-based test for a range of respiratory diseases, from COVID-19 to the common cold.

Founded 2016 Seed Total: $6.37M Biotechnology

General Information

Company Name PreDxion Bio
Founded Year 2016
Industries Biotechnology
Funding Stage Seed
Social

Get notified when PreDxion Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PreDxion Bio

PreDxion Bio is a cutting-edge biotechnology startup revolutionizing the healthcare industry with its slogan: "Pioneering accessible at-home diagnostics with a breakthrough saliva-based test for a range of respiratory diseases, from COVID-19 to the common cold." Founded in 2016, it focuses on providing affordable and user-friendly diagnostic solutions.

The company’s standout offering is its rapid, saliva-based test for detecting respiratory diseases such as COVID-19, flu, pneumonia, and the common cold. Utilizing a unique multiplexed localized surface plasmon resonance (LSPR) technology, PreDxion Bio aims to significantly advance at-home diagnostic testing.

The startup secured its last investment in a $6.25M Seed Round on 15 September 2020, with backing from notable investors like SignalFire and Hillsven Capital. This investment underscores confidence in its potential to transform healthcare diagnostics.

Taxonomy: at-home diagnostics, saliva-based test, respiratory diseases, COVID-19 testing, flu diagnostics, pneumonia detection, common cold tests, multiplexed localized surface plasmon resonance, LSPR technology, affordable diagnostics, rapid testing, user-friendly medical devices, early-stage healthcare, biotech startup

Services & Products

Online Casino Games
Slot Game Development
Bonus and Promotion Management
Player Engagement Solutions
Mobile Gaming Access

Target Customers

Online Gamblers Mobile Gamers Casual Gamers Casino Enthusiasts International Players

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 2
Investor Investor
15 Sep 2020
Seed Round •••••• 1
Investor
21 Aug 2017
Grant •••••• 2
Investor
•••• ••••
09 Jun 2016

PreDxion Bio Alternatives & Competitors

PreDxion Bio vs

We innovate diagnostic efficiency

65 employees
Internet, Manufacturing
PreDxion Bio vs

Suppliers of diagnostic reagents to laboratories within Southern Africa.

6 employees
Health Care
PreDxion Bio vs

trusted . innovative . diagnostics

Series Unknown
459 employees
Biotechnology, Health Care

FAQ About PreDxion Bio

Pioneering accessible at-home diagnostics with a breakthrough saliva-based test for a range of respiratory diseases, from COVID-19 to the common cold.
PreDxion Bio was founded in 2016.
PreDxion Bio operates in the following industries: Biotechnology.
PreDxion Bio has completed 3 funding rounds, raising a total of $6.37M. The latest funding stage is Seed.
PreDxion Bio offers: Online Casino Games, Slot Game Development, Bonus and Promotion Management, Player Engagement Solutions, Mobile Gaming Access.
Top alternatives and competitors to PreDxion Bio include Gentian Diagnostics , Reliable Diagnostic Supplies (Pty) Ltd, CORE Diagnostics, Prime Labs, LightDeck Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PreDxion Bio and Gentian Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PreDxion Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy